CY1121169T1 - Αντισωμα που δεσμευει ενα γραμμικο επιτοπο ανθρωπινου ρ53 και διαγνωστικες εφαρμογες αυτου - Google Patents
Αντισωμα που δεσμευει ενα γραμμικο επιτοπο ανθρωπινου ρ53 και διαγνωστικες εφαρμογες αυτουInfo
- Publication number
- CY1121169T1 CY1121169T1 CY20191100087T CY191100087T CY1121169T1 CY 1121169 T1 CY1121169 T1 CY 1121169T1 CY 20191100087 T CY20191100087 T CY 20191100087T CY 191100087 T CY191100087 T CY 191100087T CY 1121169 T1 CY1121169 T1 CY 1121169T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antibody
- human
- linear
- epitop
- binds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4748—Details p53
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7042—Aging, e.g. cellular aging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Η εφεύρεση αναφέρεται σε ένα αντίσωμα έναντι ανθρώπινου p53 κατάλληλο για την ειδική δέσμευση ενός γραμμικού επιτόπου που εκτίθεται μόνο σε ένα διαμορφωτικά μεταβληθέν ισόμορφο της χαρακτηριστικής πρωτεΐνης p53 ασθενών με νόσο Alzheimer ή επιρρεπών να αναπτύξουν νόσο Alzheimer ή γνωστική βλάβη κατά τη διάρκεια της γηράνσεως. Μέθοδοι και διαγνωστικές και προγνωστικές συσκευασίες περιγράφονται επίσης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITTO20140776 | 2014-09-30 | ||
PCT/EP2015/072094 WO2016050630A1 (en) | 2014-09-30 | 2015-09-25 | Antibody binding a linear epitope of human p53 and diagnostic applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1121169T1 true CY1121169T1 (el) | 2020-05-29 |
Family
ID=51904165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100087T CY1121169T1 (el) | 2014-09-30 | 2019-01-22 | Αντισωμα που δεσμευει ενα γραμμικο επιτοπο ανθρωπινου ρ53 και διαγνωστικες εφαρμογες αυτου |
Country Status (17)
Country | Link |
---|---|
US (6) | US10183990B2 (el) |
EP (1) | EP3201234B1 (el) |
JP (2) | JP6938372B2 (el) |
CN (1) | CN107001453B (el) |
CY (1) | CY1121169T1 (el) |
DK (1) | DK3201234T3 (el) |
ES (1) | ES2708556T3 (el) |
HR (1) | HRP20190017T1 (el) |
HU (1) | HUE042815T2 (el) |
LT (1) | LT3201234T (el) |
PL (1) | PL3201234T3 (el) |
PT (1) | PT3201234T (el) |
RS (1) | RS58244B1 (el) |
RU (1) | RU2741795C2 (el) |
SI (1) | SI3201234T1 (el) |
TR (1) | TR201900550T4 (el) |
WO (1) | WO2016050630A1 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3201234T (lt) | 2014-09-30 | 2019-03-12 | Diadem S.R.L. | Antikūnas, surišantis linijinį žmogaus p53 epitopą, ir jo panaudojimas diagnostikai |
KR101885007B1 (ko) * | 2016-12-22 | 2018-08-31 | 가천대학교 산학협력단 | 인지기능장애의 진단 방법 및 키트 |
EP3935394A1 (en) * | 2019-03-06 | 2022-01-12 | Diadem S.r.l. | P53 peptides as markers in the diagnosis and prognosis of alzheimer's disease |
IT202000018544A1 (it) | 2020-07-30 | 2022-01-30 | Diadem S R L | Modificazioni post-traslazionali su p-53 quali marcatori nella diagnosi e prognosi di malattia neurodegenerativa |
WO2024030982A2 (en) | 2022-08-02 | 2024-02-08 | Diadem Spa | Device for detection and prognostic assessment of neurodegenerative disorders |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224784D0 (en) * | 1992-11-26 | 1993-01-13 | Univ Dundee | Cellular protein |
AU722042B2 (en) * | 1995-11-30 | 2000-07-20 | Board Of Regents, The University Of Texas System | Methods and compositions for the diagnosis and treatment of cancer |
EP0929811A1 (en) * | 1996-10-07 | 1999-07-21 | Schering Corporation | ASSAY FOR THE DETECTION OF ANTIBODIES AGAINST p53 |
CA2350597A1 (en) * | 1998-12-02 | 2000-06-08 | Barbara Ann Foster | Methods and compositions for restoring conformational stability of a protein of the p53 family |
US20030180811A1 (en) * | 2002-03-11 | 2003-09-25 | Montero-Julian Felix A. | Immunoassays for beta2-microglobulin |
KR100595494B1 (ko) * | 2003-02-24 | 2006-07-03 | (주) 디지탈바이오텍 | 혈액 내 베타-아밀로이드 항체 농도를 이용한 알츠하이머병 진단키트 |
ITMI20031709A1 (it) | 2003-09-05 | 2005-03-06 | Uni Degli Studi Brescia | Metodo per l'individuazione precoce della malattia di alzheimer. |
US8101714B2 (en) * | 2004-02-18 | 2012-01-24 | The University Of Georgia Research Foundation, Inc. | Teleost derived antimicrobial polypeptides |
US7833513B2 (en) * | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
CN101228187A (zh) * | 2005-03-25 | 2008-07-23 | 特拉维夫大学拉莫特有限公司 | 针对突变p53的共同表位的人合成单链抗体及其用途 |
US8703734B2 (en) * | 2005-12-12 | 2014-04-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nanoprobes for detection or modification of molecules |
IL199534A (en) * | 2007-01-05 | 2013-01-31 | Univ Zuerich | An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses. |
ES2496916T3 (es) * | 2007-05-31 | 2014-09-22 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Epítopo de HPV al que se dirigen células T que infiltran tumores malignos cervicales para su uso en vacunas |
CN101796070A (zh) * | 2007-05-31 | 2010-08-04 | 莱顿教学医院 | p53肽疫苗 |
WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
JP5812418B2 (ja) * | 2009-04-17 | 2015-11-11 | イムナス・ファーマ株式会社 | Aβオリゴマーに特異的に結合する抗体およびその利用 |
CN103837686A (zh) * | 2014-03-06 | 2014-06-04 | 上海北加生化试剂有限公司 | 一种检测人免疫球蛋白g4的试剂盒及其制备方法 |
LT3201234T (lt) | 2014-09-30 | 2019-03-12 | Diadem S.R.L. | Antikūnas, surišantis linijinį žmogaus p53 epitopą, ir jo panaudojimas diagnostikai |
-
2015
- 2015-09-25 LT LTEP15767529.9T patent/LT3201234T/lt unknown
- 2015-09-25 PL PL15767529T patent/PL3201234T3/pl unknown
- 2015-09-25 JP JP2017516964A patent/JP6938372B2/ja active Active
- 2015-09-25 CN CN201580052913.0A patent/CN107001453B/zh active Active
- 2015-09-25 TR TR2019/00550T patent/TR201900550T4/tr unknown
- 2015-09-25 RU RU2017114626A patent/RU2741795C2/ru active
- 2015-09-25 EP EP15767529.9A patent/EP3201234B1/en active Active
- 2015-09-25 SI SI201530581T patent/SI3201234T1/sl unknown
- 2015-09-25 US US15/515,693 patent/US10183990B2/en active Active
- 2015-09-25 WO PCT/EP2015/072094 patent/WO2016050630A1/en active Application Filing
- 2015-09-25 RS RS20190070A patent/RS58244B1/sr unknown
- 2015-09-25 HU HUE15767529A patent/HUE042815T2/hu unknown
- 2015-09-25 DK DK15767529.9T patent/DK3201234T3/en active
- 2015-09-25 PT PT15767529T patent/PT3201234T/pt unknown
- 2015-09-25 ES ES15767529T patent/ES2708556T3/es active Active
-
2018
- 2018-12-10 US US16/214,455 patent/US10875908B2/en active Active
-
2019
- 2019-01-03 HR HRP20190017TT patent/HRP20190017T1/hr unknown
- 2019-01-22 CY CY20191100087T patent/CY1121169T1/el unknown
-
2020
- 2020-08-12 JP JP2020136359A patent/JP2020203895A/ja active Pending
- 2020-11-09 US US17/093,541 patent/US11208473B2/en active Active
- 2020-11-09 US US17/093,527 patent/US11203635B2/en active Active
-
2021
- 2021-11-17 US US17/528,946 patent/US11802148B2/en active Active
-
2023
- 2023-09-27 US US18/475,473 patent/US20240124565A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210070848A1 (en) | 2021-03-11 |
ES2708556T3 (es) | 2019-04-10 |
HRP20190017T1 (hr) | 2019-03-22 |
EP3201234B1 (en) | 2018-11-07 |
JP2017534595A (ja) | 2017-11-24 |
DK3201234T3 (en) | 2019-02-25 |
RU2741795C2 (ru) | 2021-01-28 |
PL3201234T3 (pl) | 2019-04-30 |
RU2017114626A3 (el) | 2019-04-26 |
US11802148B2 (en) | 2023-10-31 |
US11203635B2 (en) | 2021-12-21 |
WO2016050630A1 (en) | 2016-04-07 |
US10875908B2 (en) | 2020-12-29 |
US20180057572A1 (en) | 2018-03-01 |
HUE042815T2 (hu) | 2019-07-29 |
TR201900550T4 (tr) | 2019-02-21 |
US20210061895A1 (en) | 2021-03-04 |
LT3201234T (lt) | 2019-03-12 |
US11208473B2 (en) | 2021-12-28 |
EP3201234A1 (en) | 2017-08-09 |
SI3201234T1 (sl) | 2019-03-29 |
CN107001453A (zh) | 2017-08-01 |
US20220064273A1 (en) | 2022-03-03 |
RS58244B1 (sr) | 2019-03-29 |
JP2020203895A (ja) | 2020-12-24 |
JP6938372B2 (ja) | 2021-09-22 |
US20190194305A1 (en) | 2019-06-27 |
CN107001453B (zh) | 2021-07-20 |
US20240124565A1 (en) | 2024-04-18 |
US10183990B2 (en) | 2019-01-22 |
RU2017114626A (ru) | 2018-11-02 |
PT3201234T (pt) | 2019-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121169T1 (el) | Αντισωμα που δεσμευει ενα γραμμικο επιτοπο ανθρωπινου ρ53 και διαγνωστικες εφαρμογες αυτου | |
CY1122458T1 (el) | Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
CY1124408T1 (el) | ΣΤΟΧΕΥΜΕΝΗ ΑΝΑΣΤΟΛΗ TGFβ | |
CY1124384T1 (el) | Κατασκευες διπλοειδικων αντισωματων που δεσμευονται σε egfrviii και cd3 | |
CY1125440T1 (el) | Αντι-τιμ-3 αντισωματα και συνθεσεις | |
CY1122510T1 (el) | Μορια αντισωματος σε lag-3 και χρησεις αυτων | |
CY1124619T1 (el) | Αντισωματα αντι-προ/λανθανουσας μυοστατινης και χρησεις αυτων | |
MA55347A (fr) | Anticorps anti-lag3 et fragments de fixation à l'antigène | |
CY1123746T1 (el) | Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer | |
CY1124698T1 (el) | Πρωτεϊνη δεσμευσης il-18 (il-18bp) σε φλεγμονωδεις νοσους | |
MA52742A (fr) | Anticorps bispécifiques dll3-cd3 | |
MA53434A (fr) | Anticorps anti-tigit | |
CU20170169A7 (es) | Anticuerpos de factor xi | |
MA52884A (fr) | Anticorps anti-il-11 | |
CY1124563T1 (el) | Βελτιωμενα antισωmata δεσμευσης πρωτοϊνιδιων α- βητα | |
CY1123995T1 (el) | Αντισωματα ειδικα για υπερφωσφορυλιωμενη ταυ και μεθοδοι χρησης αυτων | |
MA52273A (fr) | Protéines de liaison à un antigène anti-trem2 et leurs utilisations | |
CR20170383A (es) | Anticuerpos anti-cd3, anticuerpos anti-cd-123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123 | |
DK3645570T3 (da) | VISTA-antigenbindende molekyler | |
CY1124153T1 (el) | Αντισωματα και πολυπεπτιδια που κατευθυνονται εναντι cd127 | |
MA43738A (fr) | Anticorps anti-tnfalpha et leurs fragments fonctionnels | |
MA52366A (fr) | Anticorps anti-tl1a optimisés | |
CY1120803T1 (el) | Πρωτεϊνες δεσμευσης με αντιγονο ειδικες για το συστατικο ρ αμυλοειδους ορου | |
PH12019501837A1 (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging | |
BR112017021779A2 (pt) | ?uma preparação combinada de anticorpos anti-staphylococcus aureus? |